NCT06543940View on ClinicalTrials.gov

Pharmacokinetics Vancomycin CVVHDF with OXiris Membrane

NARecruitingINTERVENTIONAL

Enrollment

8

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

August 1, 2025

Study Completion Date

December 31, 2025

Conditions

AKI - Acute Kidney Injury

Interventions

DRUG

Vancomycin

vancomycin dose is 7.5 to 10 mg/kg

Trial Locations (1)

10400

RECRUITING

Facullty of Pharmacy Mahidol University, Bangkok

All Listed Sponsors

lead

Mahidol University

OTHER